These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 19737543)
21. Effect of phosphodiesterase 7 inhibitor ASB16165 on development and function of cytotoxic T lymphocyte. Kadoshima-Yamaoka K; Murakawa M; Goto M; Tanaka Y; Inoue H; Murafuji H; Hayashi Y; Nagahira K; Miura K; Nakatsuka T; Chamoto K; Fukuda Y; Nishimura T Int Immunopharmacol; 2009 Jan; 9(1):97-102. PubMed ID: 18992850 [TBL] [Abstract][Full Text] [Related]
22. Superiority of combined phosphodiesterase PDE3/PDE4 inhibition over PDE4 inhibition alone on glucocorticoid- and long-acting β2-adrenoceptor agonist-induced gene expression in human airway epithelial cells. BinMahfouz H; Borthakur B; Yan D; George T; Giembycz MA; Newton R Mol Pharmacol; 2015 Jan; 87(1):64-76. PubMed ID: 25324049 [TBL] [Abstract][Full Text] [Related]
23. Role of Phosphodiesterase 7 (PDE7) in T Cell Activity. Effects of Selective PDE7 Inhibitors and Dual PDE4/7 Inhibitors on T Cell Functions. Szczypka M Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854348 [TBL] [Abstract][Full Text] [Related]
24. Cloning, stable expression of human phosphodiesterase 7A and development of an assay for screening of PDE7 selective inhibitors. Malik R; Bora RS; Gupta D; Sharma P; Arya R; Chaudhary S; Saini KS Appl Microbiol Biotechnol; 2008 Jan; 77(5):1167-73. PubMed ID: 17952431 [TBL] [Abstract][Full Text] [Related]
25. Identification of potent pyrimidine inhibitors of phosphodiesterase 7 (PDE7) and their ability to inhibit T cell proliferation. Guo J; Watson A; Kempson J; Carlsen M; Barbosa J; Stebbins K; Lee D; Dodd J; Nadler SG; McKinnon M; Barrish J; Pitts WJ Bioorg Med Chem Lett; 2009 Apr; 19(7):1935-8. PubMed ID: 19272774 [TBL] [Abstract][Full Text] [Related]
26. 13C-NMR investigation of protein synthesis during apoptosis in human leukemic cell lines. Scott CE; Adebodun F J Cell Physiol; 1999 Oct; 181(1):147-52. PubMed ID: 10457362 [TBL] [Abstract][Full Text] [Related]
27. Antipsychotic-like properties of phosphodiesterase 4 inhibitors: evaluation of 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with auditory event-related potentials and prepulse inhibition of startle. Halene TB; Siegel SJ J Pharmacol Exp Ther; 2008 Jul; 326(1):230-9. PubMed ID: 18420599 [TBL] [Abstract][Full Text] [Related]
28. Synthesis, Anti-inflammatory Activity and Docking Studies of Some Newer 1,3-Thiazolidine-2,4-dione Derivatives as Dual Inhibitors of PDE4 and PDE7. Sharma H; Lather V; Grewal AS; Pandita D Curr Comput Aided Drug Des; 2019; 15(3):225-234. PubMed ID: 30280674 [TBL] [Abstract][Full Text] [Related]
29. Effects of phosphodiesterase 7 inhibition by RNA interference on the gene expression and differentiation of human mesenchymal stem cell-derived osteoblasts. Pekkinen M; Ahlström MEB; Riehle U; Huttunen MM; Lamberg-Allardt CJE Bone; 2008 Jul; 43(1):84-91. PubMed ID: 18420479 [TBL] [Abstract][Full Text] [Related]
30. 19F NMR studies of changes in membrane potential and intracellular volume during dexamethasone-induced apoptosis in human leukemic cell lines. Adebodun F; Post JF J Cell Physiol; 1993 Jan; 154(1):199-206. PubMed ID: 8419404 [TBL] [Abstract][Full Text] [Related]
31. A selective phosphodiesterase 4 (PDE4) inhibitor Zl-n-91 suppresses IL-17 production by human memory Th17 cells. Ma R; Yang BY; Wu CY Int Immunopharmacol; 2008 Oct; 8(10):1408-17. PubMed ID: 18687303 [TBL] [Abstract][Full Text] [Related]
32. Glucocorticoid-receptor-gene defects and resistance to glucocorticoid-induced apoptosis in human leukemic cell lines. Hala M; Hartmann BL; Böck G; Geley S; Kofler R Int J Cancer; 1996 Nov; 68(5):663-8. PubMed ID: 8938150 [TBL] [Abstract][Full Text] [Related]
33. The cAMP signaling pathway as a therapeutic target in lymphoid malignancies. Lerner A; Kim DH; Lee R Leuk Lymphoma; 2000 Mar; 37(1-2):39-51. PubMed ID: 10721768 [TBL] [Abstract][Full Text] [Related]
34. Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL). Zauli G; Rimondi E; Celeghini C; Milani D; Secchiero P J Cell Physiol; 2010 Feb; 222(2):357-64. PubMed ID: 19877156 [TBL] [Abstract][Full Text] [Related]
35. cAMP mediates ammonia-induced programmed cell death in the microglial cell line BV-2. Svoboda N; Zierler S; Kerschbaum HH Eur J Neurosci; 2007 Apr; 25(8):2285-95. PubMed ID: 17445227 [TBL] [Abstract][Full Text] [Related]
36. Pharmacology of a novel, orally active PDE4 inhibitor. Dastidar SG; Ray A; Shirumalla R; Rajagopal D; Chaudhary S; Nanda K; Sharma P; Seth MK; Balachandran S; Gupta N; Palle V Pharmacology; 2009; 83(5):275-86. PubMed ID: 19321962 [TBL] [Abstract][Full Text] [Related]
37. Optimization and validation of a reporter gene assay for screening of phosphodiesterase inhibitors in a high throughput system. Nanda K; Chatterjee M; Arya R; Mukherjee S; Saini KS; Dastidar S; Ray A Biotechnol J; 2008 Oct; 3(9-10):1276-9. PubMed ID: 18655041 [TBL] [Abstract][Full Text] [Related]
38. [Cyclic nucleotide phosphodiesterase IV expression, activity and targeting in cells of cardiovascular system]. Yan J; Zhu HB Yao Xue Xue Bao; 2007 Jun; 42(6):571-5. PubMed ID: 17702390 [TBL] [Abstract][Full Text] [Related]
39. Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids. Herr I; Gassler N; Friess H; Büchler MW Apoptosis; 2007 Feb; 12(2):271-91. PubMed ID: 17191112 [TBL] [Abstract][Full Text] [Related]
40. 31P NMR characterization of cellular metabolism during dexamethasone induced apoptosis in human leukemic cell lines. Adebodun F; Post JF J Cell Physiol; 1994 Jan; 158(1):180-6. PubMed ID: 8263024 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]